LMBR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.867200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.928000E-01
Normal-vs-Stage2
5.886000E-01
Normal-vs-Stage3
4.158200E-01
Normal-vs-Stage4
7.685200E-01
Stage1-vs-Stage2
7.665200E-01
Stage1-vs-Stage3
2.117600E-02
Stage1-vs-Stage4
5.612200E-01
Stage2-vs-Stage3
1.298620E-01
Stage2-vs-Stage4
8.138000E-01
Stage3-vs-Stage4
2.563000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.066000E-01
Normal-vs-AfricanAmerican
2.922400E-01
Normal-vs-Asian
8.923000E-01
Caucasian-vs-AfricanAmerican
2.556400E-01
Caucasian-vs-Asian
5.012200E-01
AfricanAmerican-vs-Asian
2.118000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.959600E-01
Normal-vs-Female
5.854200E-01
Male-vs-Female
9.737000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.437000E-01
Normal-vs-Age(41-60Yrs)
3.037400E-01
Normal-vs-Age(61-80Yrs)
7.791800E-01
Normal-vs-Age(81-100Yrs)
8.410400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.680400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.789200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.328150E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.041400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.859330E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.880800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.148200E-01
Normal-vs-Daily Drinker
7.878400E-01
Normal-vs-Weekly Drinker
6.556600E-01
Normal-vs-Occasional Drinker
5.091600E-01
Normal-vs-Social Drinker
3.768400E-01
Non Drinker-vs-Daily Drinker
8.796800E-01
Non Drinker-vs-Weekly Drinker
6.034200E-01
Non Drinker-vs-Occasional Drinker
2.726000E-01
Non Drinker-vs-Social Drinker
1.066410E-01
Daily Drinker-vs-Weekly Drinker
7.362200E-01
Daily Drinker-vs-Occasional Drinker
4.017600E-01
Daily Drinker-vs-Social Drinker
1.384600E-01
Weekly Drinker-vs-Occasional Drinker
6.633800E-01
Weekly Drinker-vs-Social Drinker
2.380000E-01
Occasional Drinker-vs-Social Drinker
3.549200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.834600E-01
Normal-vs-Grade 2
8.515400E-01
Normal-vs-Grade 3
7.818400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.706400E-01
Grade 1-vs-Grade 3
9.928000E-01
Grade 1-vs-Grade 4
5.834600E-01
Grade 2-vs-Grade 3
1.869570E-01
Grade 2-vs-Grade 4
8.515400E-01
Grade 3-vs-Grade 4
7.818400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.340400E-01
Normal-vs-NonDiabetic
5.840400E-01
Diabetic-vs-NonDiabetic
2.610200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.964600E-01
Normal-vs-NoPancreatitis
6.698600E-01
Pancreatitis-vs-NoPancreatitis
4.868800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.076600E-01
Normal-vs-N1
5.945400E-01
N0-vs-N1
7.753600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.296600E-01
Normal-vs-TP53-NonMutant
4.711800E-01
TP53-Mutant-vs-TP53-NonMutant
7.229400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
